Showing 1,841 - 1,860 results of 99,774 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( 5 ((fold decrease) OR (nn decrease)) ))', query time: 1.59s Refine Results
  1. 1841

    Spatial information is significantly decreased in dCA1 and vCA1 in APP/PS1 mice. by Udaysankar Chockanathan (18510288)

    Published 2024
    “…(B) In dCA1, spatial information was decreased in APP/PS1 mice relative to C57BL/6 controls (mean ± std: C57BL/6 = 0.132 ± 0.048, APP/PS1 = 0.128 ± 0.051, p < 0.005, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 305 units from 5 recording sessions, n<sub>APP/PS1</sub> = 180 units from 4 recording sessions). …”
  2. 1842
  3. 1843

    TIP47 is involved in HCV RNA replication <i>via</i> interaction with NS5A. by Dorothee A. Vogt (247917)

    Published 2013
    “…E) Coimmunoprecipitation assays in Huh7 cells transfected with expression vectors for Myc-TIP47 and NS5A-Flag or NS5A-Flag protein carrying either A<sub>9</sub>-I<sub>12</sub> (W9A), W<sub>9</sub>-I<sub>12</sub>, or A<sub>9</sub>-V<sub>12</sub> mutations. …”
  4. 1844

    Fluorescence of 5-Arylvinyl-5′-Methyl-2,2′-Bipyridyl Ligands and Their Zinc Complexes by Ali H. Younes (1589731)

    Published 2009
    “…The photophysical properties of 5-arylvinyl-5′-methyl-2,2′-bipyridyls (AVMBs, <b>1</b>−<b>9</b>, <b>11</b>) and their zinc complexes were studied. …”
  5. 1845
  6. 1846
  7. 1847
  8. 1848
  9. 1849

    Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

    Published 2015
    “…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”
  10. 1850

    Different response of visASCs to a micro-local oxygen concentration decrease in metabolically active sites of the adipose tissue. by Wilfredo Oliva-Olivera (301968)

    Published 2017
    “…However, hypox-visASCs from MS patients show a lower ability to actively participate in or stimulate the formation of microvascular structures, while they favor the accumulation of CD11C<sup>+</sup> and CD163<sup>+</sup> macrophages in the adipose tissue through their contribution to the increased tissue levels of MCP1. ↑ Increased response; <b>↓</b> Decreased response; → Hypox-visASCs main response NonMS: obese subjects without metabolic syndrome; MS: obese subjects with metabolic syndrome; visASC: visceral adipose tissue-derived multipotent mesenchymal cells; hypox-visASCs: visASC under hypoxia; NOX5: NADPH Oxidase 5; SDF1α: stromal cell-derived factor 1α; VEGF: vascular endothelial growth factor; MCP1: monocyte chemoattractant protein 1; CD11C<sup>+</sup>, CD163<sup>+</sup>: proinflammatory macrophage cell-surface markers.…”
  11. 1851
  12. 1852
  13. 1853
  14. 1854
  15. 1855
  16. 1856
  17. 1857

    Expanding Three-Coordinate Gold(I) Anticancer Agent Chemical Space by Charles E. Greif (21728091)

    Published 2025
    “…The complexes demonstrated submicromolar cytotoxic activity against human breast cancer cells MDA-MB-231 or MDA-MB-468 with IC<sub>50</sub>’s in the range of 0.4–5.0 μM. Complex <b>2e</b> shows high potency in vitro and decreases 3D-breast cancer mammosphere viability. …”
  18. 1858
  19. 1859
  20. 1860